PK of Rivaroxaban in Bariatric Patients - Extension

NCT02832947 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

13

Enrollment

OTHER

Sponsor class

Conditions

Prophylaxis of Venous Thromboembolism

Interventions

DRUG: Rivaroxaban 10 mg

Sponsor

Insel Gruppe AG, University Hospital Bern

Collaborators

[object Object]